Ullern, A., Garborg, K. K., Chauhan, S. K., Holm, K., Bang, C., Dunn, C., Johnsen, P. H., Hov, J. E. R., Kyte, J. A.

Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial

20 de July de 2026 by Ullern, A., Garborg, K. K., Chauhan, S. K., Holm, K., Bang, C., Dunn, C., Johnsen, P. H., Hov, J. E. R., Kyte, J. A.

Background
Fecal microbiota transplantation (FMT) has shown promise in overcoming resistance to immune checkpoint inhibitors (ICIs) in early-phase cancer trials. We investigated the safety, feasibility and efficacy of FMT from ICI responders to patien…